TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of a Weight Management Program for Overweight and Obese Children: a Randomized Controlled Trial
Brief Summary: The purpose of this study, and its original contribution to research, is to determine the impact of a physical activity skill development and parent centered family weight management program on the weight, cardiovascular health, physical activity, dietary intake and sedentary behaviors of overweight and obese children.


Options:
A: Intervention Type: BEHAVIORAL; Name: Diet with increased fruits, vegetables, and calcium; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Increased high impact activity and resistance training; Assigned to Arm(s): N/A
B: Intervention Type: BEHAVIORAL; Name: Physical activity and diet; Assigned to Arm(s): N/A
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: School children and adolescents as health experts | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: School children and adolescents as health experts; Assigned to Arm(s): A
D: Arm Label: Activity prescription; Type: EXPERIMENTAL; Interventions: Other: Activity Knowledge Circuits | Arm Label: Normal Curriculum; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Activity Knowledge Circuits; Assigned to Arm(s): Activity prescription

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of a Weight Management Program for Overweight and Obese Children: a Randomized Controlled Trial
Brief Summary: The purpose of this study, and its original contribution to research, is to determine the impact of a physical activity skill development and parent centered family weight management program on the weight, cardiovascular health, physical activity, dietary intake and sedentary behaviors of overweight and obese children.


Options:
A: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Behavioral: Education, Behavioral: Problem Solving, Behavioral: Social Learning, Behavioral: Behavior Modification | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Group A, Group B | Intervention Type: BEHAVIORAL; Name: Problem Solving; Assigned to Arm(s): Group A | Intervention Type: BEHAVIORAL; Name: Social Learning; Assigned to Arm(s): Group A | Intervention Type: BEHAVIORAL; Name: Behavior Modification; Assigned to Arm(s): Group A
B: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self monitoring | Arm Label: Daily reward; Type: EXPERIMENTAL; Interventions: Behavioral: Monetary incentives, Behavioral: Self monitoring | Arm Label: Delayed reward; Type: EXPERIMENTAL; Interventions: Behavioral: Monetary incentives, Behavioral: Self monitoring | Intervention Type: BEHAVIORAL; Name: Monetary incentives; Assigned to Arm(s): Daily reward, Delayed reward | Intervention Type: BEHAVIORAL; Name: Self monitoring; Assigned to Arm(s): Control, Daily reward, Delayed reward
C: Intervention Type: BEHAVIORAL; Name: Physical activity and diet; Assigned to Arm(s): N/A
D: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Lifestyle counseling; Assigned to Arm(s): Lifestyle counseling

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of a Weight Management Program for Overweight and Obese Children: a Randomized Controlled Trial
Brief Summary: The purpose of this study, and its original contribution to research, is to determine the impact of a physical activity skill development and parent centered family weight management program on the weight, cardiovascular health, physical activity, dietary intake and sedentary behaviors of overweight and obese children.


Options:
A: Intervention Type: BEHAVIORAL; Name: Physical activity and diet; Assigned to Arm(s): N/A
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group
C: Arm Label: CHL program; Type: EXPERIMENTAL; Interventions: Other: CHL program | Arm Label: Delayed Optimized CHL program; Type: OTHER; Interventions: Other: Delayed Optimized CHL program | Arm Label: Temporal; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: CHL program; Assigned to Arm(s): CHL program | Intervention Type: OTHER; Name: Delayed Optimized CHL program; Assigned to Arm(s): Delayed Optimized CHL program
D: Arm Label: Nutrition and Physical Activity; Type: EXPERIMENTAL; Interventions: Behavioral: The Food Friends | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The Food Friends; Assigned to Arm(s): Nutrition and Physical Activity

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of a Weight Management Program for Overweight and Obese Children: a Randomized Controlled Trial
Brief Summary: The purpose of this study, and its original contribution to research, is to determine the impact of a physical activity skill development and parent centered family weight management program on the weight, cardiovascular health, physical activity, dietary intake and sedentary behaviors of overweight and obese children.


Options:
A: Intervention Type: BEHAVIORAL; Name: Targeted parental instruction for positive lifestyle change with follow-up calls.; Assigned to Arm(s): N/A
B: Arm Label: Cognitive Behavioural Therapy (CBT); Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioural Therapy (CBT), Behavioral: Psycho-Education Program (PEP) | Arm Label: Psycho-Education Program (PEP); Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioural Therapy (CBT), Behavioral: Psycho-Education Program (PEP) | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioural Therapy (CBT); Assigned to Arm(s): Cognitive Behavioural Therapy (CBT), Psycho-Education Program (PEP) | Intervention Type: BEHAVIORAL; Name: Psycho-Education Program (PEP); Assigned to Arm(s): Cognitive Behavioural Therapy (CBT), Psycho-Education Program (PEP)
C: Intervention Type: BEHAVIORAL; Name: Physical activity and diet; Assigned to Arm(s): N/A
D: Arm Label: parent intervention plus gym lessons; Type: EXPERIMENTAL; Interventions: Behavioral: parent-focused intervention, Behavioral: twice weekly gym lessons | Arm Label: gym lessons only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: twice weekly gym lessons | Intervention Type: BEHAVIORAL; Name: parent-focused intervention; Assigned to Arm(s): parent intervention plus gym lessons | Intervention Type: BEHAVIORAL; Name: twice weekly gym lessons; Assigned to Arm(s): gym lessons only, parent intervention plus gym lessons

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Phase II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Oral Neurokinin-1 Receptor Antagonist, GW679769, When Administered With Intravenous Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting (PONV) and Post-discharge Nausea and Vomiting (PDNV) in Female Subjects With Known Risk Factors for PONV Who Are Undergoing Surgical Procedures Associated With an Increased Emetogenic Risk
Brief Summary: This study is looking at a range of doses of this NK-1 receptor antagonist drug, for both safety and effectiveness in prevention PONV


Options:
A: Intervention Type: DRUG; Name: MK0869, aprepitant; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Comparator: ondansetron IV; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: intravenous ondansetron; Assigned to Arm(s): N/A
C: Arm Label: Aprepitant group; Type: EXPERIMENTAL; Interventions: Drug: Aprepitant | Arm Label: placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Aprepitant; Assigned to Arm(s): Aprepitant group | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo group
D: Arm Label: Palonosetron group; Type: N/A; Interventions: N/A | Arm Label: Granisetron group; Type: N/A; Interventions: N/A | Arm Label: Ramosetron group; Type: N/A; Interventions: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Tailored Cognitive-Behavioral Therapy for Chronic Back Pain
Brief Summary: This clinical trial compares two psychological treatments for back pain.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: tailored cognitive behavior therapy, Behavioral: standard care | Intervention Type: BEHAVIORAL; Name: tailored cognitive behavior therapy; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: standard care; Assigned to Arm(s): Arm 1
B: Arm Label: Cognitive Behavioral Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Mindfulness-Based Stress Reduction; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mindfulness Based Stress Reduction | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Stress Reduction; Assigned to Arm(s): Mindfulness-Based Stress Reduction
C: Arm Label: Prescribed physical activity; Type: OTHER; Interventions: Other: Prescribed physical activity | Arm Label: Neck specific training; Type: OTHER; Interventions: Other: Neck specific training | Intervention Type: OTHER; Name: Prescribed physical activity; Assigned to Arm(s): Prescribed physical activity | Intervention Type: OTHER; Name: Neck specific training; Assigned to Arm(s): Neck specific training
D: Arm Label: Back school; Type: EXPERIMENTAL; Interventions: Behavioral: back school | Arm Label: back school; Type: EXPERIMENTAL; Interventions: Behavioral: back school | Intervention Type: BEHAVIORAL; Name: back school; Assigned to Arm(s): Back school, back school

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Integrated CBT for Substance Use and Depressive Disorders
Brief Summary: The purpose of this study is to determine whether Integrated Cognitive Behavioral Therapy or Twelve Step Facilitation Therapy is most effective for treatment of dually diagnosed veterans with depressive and substance use disorders.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Cognitive Behavioral Therapy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Twelve Step Facilitation Therapy | Intervention Type: BEHAVIORAL; Name: Integrated Cognitive Behavioral Therapy; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Twelve Step Facilitation Therapy; Assigned to Arm(s): 2
B: Arm Label: Traditional Contingency Management; Type: EXPERIMENTAL; Interventions: Behavioral: Traditional Contingency Management | Arm Label: Early Enhanced Contingency Management; Type: EXPERIMENTAL; Interventions: Behavioral: Early Enhanced Contingency Management | Arm Label: Standard Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Treatment | Intervention Type: BEHAVIORAL; Name: Standard Treatment; Assigned to Arm(s): Standard Treatment | Intervention Type: BEHAVIORAL; Name: Traditional Contingency Management; Assigned to Arm(s): Traditional Contingency Management | Intervention Type: BEHAVIORAL; Name: Early Enhanced Contingency Management; Assigned to Arm(s): Early Enhanced Contingency Management
C: Arm Label: Family Spirit Intervention; Type: EXPERIMENTAL; Interventions: Procedure: Family Spirit Intervention | Arm Label: Optimized Standard Care Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Family Spirit Intervention; Assigned to Arm(s): Family Spirit Intervention
D: Arm Label: Integrated care; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated care | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Integrated care; Assigned to Arm(s): Integrated care | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Linezolid vs Vancomycin/Cefazolin in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
Brief Summary: This study will treat hemodialysis patients who have a central catheter that is thought to be infected with a specific bacteria (Gram positive bacteria).


Options:
A: Arm Label: ethanol; Type: EXPERIMENTAL; Interventions: Other: Ethanol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Ethanol | Intervention Type: OTHER; Name: Ethanol; Assigned to Arm(s): ethanol, placebo
B: Arm Label: NAC/Tigecycline/Heparin combination lock solution; Type: EXPERIMENTAL; Interventions: Drug: NAC/Tigecycline/Heparin combination lock solution | Arm Label: Standard anticoagulant (heparin or citrate); Type: PLACEBO_COMPARATOR; Interventions: Drug: Standard anticoagulant (Heparin or Citrate) | Intervention Type: DRUG; Name: NAC/Tigecycline/Heparin combination lock solution; Assigned to Arm(s): NAC/Tigecycline/Heparin combination lock solution | Intervention Type: DRUG; Name: Standard anticoagulant (Heparin or Citrate); Assigned to Arm(s): Standard anticoagulant (heparin or citrate)
C: Intervention Type: DRUG; Name: Cefazolin IV; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Linezolid IV; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Vancomycin (IV); Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Ethanol; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Efficacy of Low Carbohydrate Diet in Obesity and Type 2 DM: RCT
Brief Summary: This study is designed to address the hypothesis that in obese patients with type 2 diabetes mellitus (DM), a low carbohydrate diet not specifically restricted in calories compared to low fat, caloric restricted diet over 24 months will cause 5% greater reduction in body weight in patients with obesity and type 2 DM, be safe, and will not have any detrimental effects on serum lipid concentrations.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Choice | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Choice; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Arm 2
B: Intervention Type: BEHAVIORAL; Name: dietary intervention; Assigned to Arm(s): N/A
C: Arm Label: High fat low carbohydrate diet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: High fat low carbohydrate diet | Arm Label: Low fat high carbohydrate diet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Low fat high carbohydrate diet | Intervention Type: DIETARY_SUPPLEMENT; Name: High fat low carbohydrate diet; Assigned to Arm(s): High fat low carbohydrate diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Low fat high carbohydrate diet; Assigned to Arm(s): Low fat high carbohydrate diet
D: Intervention Type: BEHAVIORAL; Name: Low Carbohydrate Diet; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Antidepressants in Chronic Back Pain
Brief Summary: The purpose of this study is to determine whether gabapentin is efficacious as an analgesic for chronic low back pain.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: gabapentin | Arm Label: 2; Type: SHAM_COMPARATOR; Interventions: Drug: Inert placebo | Intervention Type: DRUG; Name: gabapentin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Inert placebo; Assigned to Arm(s): 2
B: Arm Label: Gabapentin lower dose alone; Type: EXPERIMENTAL; Interventions: Drug: Gabapentin lower dose | Arm Label: Gabapentin higher dose alone; Type: ACTIVE_COMPARATOR; Interventions: Other: Placebo (Dop) | Arm Label: Gabapentin in combination with donepezil; Type: EXPERIMENTAL; Interventions: Drug: Donepezil, Drug: Gabapentin higher dose | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo (Gaba) | Intervention Type: DRUG; Name: Gabapentin lower dose; Assigned to Arm(s): Gabapentin lower dose alone | Intervention Type: DRUG; Name: Donepezil; Assigned to Arm(s): Gabapentin in combination with donepezil | Intervention Type: OTHER; Name: Placebo (Dop); Assigned to Arm(s): Gabapentin higher dose alone | Intervention Type: OTHER; Name: Placebo (Gaba); Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Gabapentin higher dose; Assigned to Arm(s): Gabapentin in combination with donepezil
C: Arm Label: G-ER; Type: EXPERIMENTAL; Interventions: Drug: Gabapentin Extended Release tablets | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Gabapentin Extended Release tablets; Assigned to Arm(s): G-ER | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: Gabapentin extended-release tablets; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Divalproex Sodium in the Treatment of PTSD: A Placebo-Controlled Study
Brief Summary: The purposes of this study are:

* To study the efficacy of divalproex in the treatment of PTSD;
* To study the plasma GABA (gamma aminobutyric acid) levels before and after treatment with divalproex in PTSD.


Options:
A: Arm Label: Topiramate; Type: EXPERIMENTAL; Interventions: Drug: Topiramate, Drug: placebo control group | Arm Label: Placebo Control group; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo control group | Intervention Type: DRUG; Name: Topiramate; Assigned to Arm(s): Topiramate | Intervention Type: DRUG; Name: placebo control group; Assigned to Arm(s): Placebo Control group, Topiramate
B: Arm Label: Arm 1; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: Divalproex | Intervention Type: DRUG; Name: Divalproex; Assigned to Arm(s): Arm 2 | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Arm 1
C: Arm Label: CBT no choice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive behavioral therapy (CBT) | Arm Label: CBT choice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive behavioral therapy (CBT) | Arm Label: sertraline no choice; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sertraline | Arm Label: sertraline choice; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sertraline | Intervention Type: DRUG; Name: Sertraline; Assigned to Arm(s): sertraline choice, sertraline no choice | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy (CBT); Assigned to Arm(s): CBT choice, CBT no choice
D: Arm Label: Propranolol; Type: EXPERIMENTAL; Interventions: Drug: Propranolol is available in generic form as the Wyeth product under the trade name Inderal. | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Propranolol is available in generic form as the Wyeth product under the trade name Inderal. | Intervention Type: DRUG; Name: Propranolol is available in generic form as the Wyeth product under the trade name Inderal.; Assigned to Arm(s): Placebo, Propranolol

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 12 Month Double-blind, Randomized, Parallel-group, Placebo-controlled, Multi-center Trial to Investigate the Efficacy and Safety of Vagifem Low Dose (10 mcg 17beta-estradiol Vaginal Tablet) for the Treatment of Postmenopausal Atrophic Vaginitis Symptoms
Brief Summary: This trial is conducted in North America. The purpose of this study is to determine if Vagifem Low Dose is an effective and safe treatment for patients suffering from postmenopausal atrophic vaginitis.


Options:
A: Arm Label: Treatment 1; Type: EXPERIMENTAL; Interventions: Drug: Estradiol, Drug: Progesterone, Drug: Placebo | Arm Label: Treatment 2; Type: EXPERIMENTAL; Interventions: Drug: Estradiol, Drug: Progesterone, Drug: Placebo | Arm Label: Treatment 3; Type: EXPERIMENTAL; Interventions: Drug: Estradiol, Drug: Progesterone, Drug: Placebo | Arm Label: Treatment 4; Type: EXPERIMENTAL; Interventions: Drug: Estradiol, Drug: Progesterone, Drug: Placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Estradiol; Assigned to Arm(s): Treatment 1, Treatment 2, Treatment 3, Treatment 4 | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Treatment 1, Treatment 2, Treatment 3, Treatment 4 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo, Treatment 1, Treatment 2, Treatment 3, Treatment 4
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Bazedoxifene/Conjugate Estrogens (CE) | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Raloxifene | Arm Label: C; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Bazedoxifene/Conjugate Estrogens (CE); Assigned to Arm(s): A | Intervention Type: DRUG; Name: Raloxifene; Assigned to Arm(s): B | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): C
C: Intervention Type: DRUG; Name: estradiol, 10 mcg; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: estradiol, 10 mcg; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estradiol, 25 mcg; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): N/A

Answer: C